PharmaBoardroom

HiFiBiO CEO on the Keys to Global Biotech Success

HiFiBiO Therapeutics cofounder, CEO and CSO Dr Liang Schweizer fits the profile of a Chinese biotech CEO to a T: advanced degrees in different…

Harjit Gill – CEO, APACMed

In an exclusive and wide-ranging interview, Harjit Gill outlines the work of pan-Asia-Pacific medtech association APACMed, how COVID-19 represents a…

After Brexit: Focus on the New Pharmaceutical Strategy for Europe

Writing in the February edition of DIA’s Global Forum magazine, Thomas Kühler of Sanofi R&D looks at the future of European pharma post-Brexit,…

New Drug Approvals in China in 2020

Writing in the February edition of DIA’s Global Forum magazine, Xu Wang of Novo Nordisk Pharma China and Xiaoxi Wang from the Shanghai Center for…

Russia: $7.4 bln for Healthcare Modernisation; Generics Push;…

The latest news from Russian pharma and healthcare including a big funding injection for primary care up to 2025, limits on pharma companies’…

The Long Read / Norway: Unlocking Potential

Equality has long been a deeply held ideal in Norway, where the concept of allemannsretten – the legal right to roam – permeates all aspects of…

Vaccines: Manufacturing & Supply Chain Complexity

Pharma industry insiders view vaccines as one of the most challenging products to manufacture, fundamentally due to the inherent biological…

Building a Health Data Ecosystem in Switzerland

Although Switzerland is ahead of many of its competitors in Europe on levels of healthcare innovation, one potential stumbling block is access to and…

Swissmedic New Drug Approvals 2020

Regarded as one of the world’s leading regulatory bodies, Swissmedic stands alongside its equivalents in Europe, Japan, Canada, and Australia in…

US FDA Drug Approvals 2020

In 2020, the US FDA's Center for Drug Evaluation & Research (CDER) approved 53 novel drugs, up from 48 in 2019, across a range of therapeutic…

Jacques Marbehant – Senior Vice President, Head of Global…

Belgian champion UCB's global manufacturing head, Jacques Marbehant, talks candidly about managing a broad global manufacturing and supply chain…

Liang Schweizer – CEO & CSO, HiFiBiO Therapeutics

Dr Liang Schweizer introduces immunotherapy-focused biotech HiFiBiO Therapeutics, the main advantages of the company’s unique single-cell technology…

Tagged with R